Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001721425 | SCV000533757 | likely benign | not provided | 2021-10-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000548744 | SCV000652310 | benign | Ehlers-Danlos syndrome, kyphoscoliotic type, 2 | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279213 | SCV002565997 | likely benign | Ehlers-Danlos syndrome | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348242 | SCV002623036 | benign | Cardiovascular phenotype | 2019-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001721425 | SCV004032728 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | FKBP14: BP4, BS2 |